The British journal of ophthalmology۲٬۰۲۶کارآزمایی بالینی تصادفینمایه شده در PubMed
Shuo Zhao, Miaoqin Wu, Jingxiang Zhong, Baihua Chen, Zongming Song, Zhang Ming, Quanhong Han, Suqin Yu, Hong Wang, Songtao Yuan, Jin Yao, Mingwei Zhao, Xiaohong Meng, Feng Wang, Jing Lou, Yanli Liu, Haomin Huang, Qinghong Zhou, Yuyu Xu, Hong Dai, Xiaorong Li
چکیده
While anti-vascular endothelial growth factor (VEGF) therapies are effective for macular oedema secondary to retinal vein occlusion (RVO), there remains a need for additional treatment options. This study evaluated the novel anti-VEGF agent 601 versus ranibizumab in patients with branch RVO (BRVO)…
متن کامل چکیده در سایت ناشر در دسترس است.
DOI: 10.1136/bjo-2025-327845